Top compounds associated with response to C16orf92


Feature Type Standardized
Nominal ANOVA
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 3e-07
mRNA PL-DI CTRPv2 pan-cancer AAC 0.16 9e-07
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA prima-1 CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA BIBR-1532 CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.16 3e-06
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 6e-06
Download CSV